|
Volumn 283, Issue 9, 2000, Pages 1131-
|
From the Food and Drug Administration.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEXAROTENE;
CELECOXIB;
CISAPRIDE;
GASTROINTESTINAL AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
RETINOIC ACID RECEPTOR;
SULFONAMIDE;
TETRALIN DERIVATIVE;
ARTICLE;
COLON POLYPOSIS;
CUTANEOUS T CELL LYMPHOMA;
DRUG CONTRAINDICATION;
DRUG EFFECT;
DRUG LABELING;
HUMAN;
ADENOMATOUS POLYPOSIS COLI;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTINEOPLASTIC AGENTS;
CISAPRIDE;
CYCLOOXYGENASE INHIBITORS;
DRUG LABELING;
GASTROINTESTINAL AGENTS;
HUMANS;
LYMPHOMA, T-CELL, CUTANEOUS;
PYRAZOLES;
RECEPTORS, RETINOIC ACID;
SULFONAMIDES;
TETRAHYDRONAPHTHALENES;
|
EID: 0034145666
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.283.9.1131-jfd00001-3-1 Document Type: Article |
Times cited : (24)
|
References (0)
|